Briefing: Pharma Delays Launches in Europe Amid U.S. Pressure
Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S.
Editorial Staff Mar 31
Medicine
Latest Medicine stories from Life.
Briefing: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Strategic angle: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Editorial Staff Mar 31
Briefing: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting
Strategic angle: Takeda Pharmaceuticals, the largest biopharma employer in Mass., will lay off 250 workers in Cambridge beginning in July.
Editorial Staff Mar 30
Briefing: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Editorial Staff Mar 30
Briefing: Biogen Lupus Drug Shows Promise in Mid-Stage Study
Strategic angle: The drug demonstrates improved skin clearance, marking a significant advancement in lupus treatment.
Editorial Staff Mar 30
Briefing: Trump Pushes Drug Pricing Policy Amid Biotech Developments
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Editorial Staff Mar 30
Briefing: LA County Sheriff's Deputy Dies After Medical Emergency During Relay Race
Strategic angle: Levi Vargas, 30, faced a tragic incident while competing in the Baker to Vegas race amid extreme heat conditions.
Editorial Staff Mar 29
Briefing: How to navigate the maze of drug discounts to get the best price
Strategic angle: In February, TrumpRx joined a growing list of websites consumers can tap for discounts on their medicines. Here's a cheat sheet for getting the best deal.
Editorial Staff Mar 29
Briefing: White House Works to Win Pharma Support for Drug Pricing Bill
Strategic angle: The White House is working to build support for drug pricing legislation, part of an election year focus on affordability.
Editorial Staff Mar 27
Briefing: From engineered fungal molecules to drug leads, chem-bio hybrid synthesis enables antiparasitic drug discovery
Strategic angle: Amebiasis, caused by Entamoeba histolytica, affects millions globally, highlighting the need for innovative drug discovery methods.
Editorial Staff Mar 27
FDA Approves Denali Therapeutics Drug for Hunter Syndrome
A significant decision by the FDA following previous rejections of rare disease treatments.
Editorial Staff Mar 26
Briefing: Heart failure is common. A quick MRI could improve diagnosis and guide treatment
Strategic angle: A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study heart failure and metabolism.
Editorial Staff Mar 25
Briefing: Federal vaccine adviser departs ACIP
Strategic angle: Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.
Editorial Staff Mar 24
Briefing: Pharmalittle: Trump Drug Pricing Flaw and Gilead Deal Insights
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
Editorial Staff Mar 24
Briefing: New lipid nanoparticle design improves precision of mRNA vaccine delivery
Strategic angle: Penn Engineers have redesigned a key component of lipid nanoparticles to enhance targeting and reduce off-target effects.
Editorial Staff Mar 24
Briefing: The potential loophole in Trump’s plan to get other countries to pay more for drugs
Strategic angle: Diverging messages on the main effort to address U.S. drug prices point to a loophole in Trump's plan.
Editorial Staff Mar 24
Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
Editorial Staff Mar 23
Briefing: Pfizer’s Lyme Vaccine Results Set Up Tricky Regulatory Path
Strategic angle: New results on Pfizer's Lyme disease vaccine raise questions about its regulatory approval.
Editorial Staff Mar 23
Briefing: Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle
Strategic angle: A new vaccine shows some promise in combating Lyme disease, which affects nearly half a million Americans annually.
Editorial Staff Mar 23
Briefing: India news: New Delhi sends medical aid to Afghanistan
Strategic angle: India has dispatched 2.5 tons of emergency medical supplies to Kabul following a recent airstrike.
Editorial Staff Mar 21